Geopolitical, Macroeconomic, and Regulatory Changes Impacting the Pharmaceutical Industry
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Within the first 100 days of the current US Administration, there have been a series of changes in the US that will impact the pharmaceutical industry.
To date, key outcomes have included:
• Leadership changes across the Department of Health and Human Services (HHS)
• Major cuts across key departments and health programs
• Additional regulations that may curb investments
• Introduction of a reciprocal tariff framework
• Significant tariffs on strategic sectors such as steel, aluminum, and automotive and potential tariffs on pharmaceuticals
• Heightened tensions between the US and China
Scope
This report examines the transition of the 47th U.S. Administration toward a protectionist trade policy during its first 100 days.
The analysis focuses on efforts to reduce the trade deficit while assessing the broader implications for domestic industry and global trade relations.
Table of Contents
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Services reports